1. Home
  2. CPZ vs ATYR Comparison

CPZ vs ATYR Comparison

Compare CPZ & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Calamos Long/Short Equity & Dynamic Income Trust

CPZ

Calamos Long/Short Equity & Dynamic Income Trust

HOLD

Current Price

$13.34

Market Cap

269.2M

Sector

Finance

ML Signal

HOLD

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.80

Market Cap

73.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPZ
ATYR
Founded
N/A
2005
Country
United States
United States
Employees
N/A
58
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
269.2M
73.7M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
CPZ
ATYR
Price
$13.34
$0.80
Analyst Decision
Hold
Analyst Count
0
9
Target Price
N/A
$3.67
AVG Volume (30 Days)
90.4K
958.8K
Earning Date
01-01-0001
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.13
$0.64
52 Week High
$16.82
$7.29

Technical Indicators

Market Signals
Indicator
CPZ
ATYR
Relative Strength Index (RSI) 34.58 45.27
Support Level $13.13 $0.68
Resistance Level $15.13 $0.85
Average True Range (ATR) 0.29 0.05
MACD -0.01 0.00
Stochastic Oscillator 32.00 46.92

Price Performance

Historical Comparison
CPZ
ATYR

About CPZ Calamos Long/Short Equity & Dynamic Income Trust

Calamos L/S Equity & Dynamic Inc Trust is a trust company that seeks to provide current income and risk-managed capital appreciation, with an investment objective to deliver total return through a combination of capital appreciation and current income. The Fund invests in securities across sectors such as Industrials, Healthcare, Financials, Consumer Discretionary, and others, and holds securities with a broad range of maturities, with the average term to maturity typically ranging from two to ten years. Managed assets represent the Fund's total assets, including any assets attributable to leverage that may be outstanding, minus total liabilities other than debt representing financial leverage.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

Share on Social Networks: